This Article contains typographical errors.
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Correction to: Scientific Reports https://doi.org/10.1038/s41598-018-23423-1, published online 22 March 2018 This Article contains typographical errors.
In the Results section under subheading 'Rifampin Binding in M. leprae RNAP' , "As the activity of rifampin relies on its ability to induce a steric clash with the 5′-ribonucleotide, mutations that influence its orientation in the binding pocket might lead to reduction in these steric clashes resulting inseset_name sele rifampin resistance. " should read:
"As the activity of rifampin relies on its ability to induce a steric clash with the 5′-ribonucleotide, mutations that influence its orientation in the binding pocket might lead to reduction in these steric clashes resulting in rifampin resistance. "
In the Discussion section, "Lepromatous leprosy (LL) is characterized by high bacillary loads and low M. leprae specific cell-mediated immune responses 32 in the host, increasing likelihood of the presence of bacterial persisters post-treatment which may adopt to rifampin by inducing point mutations with the RRDR. " should read:
"Lepromatous leprosy (LL) is characterized by high bacillary loads and low M. leprae specific cell-mediated immune responses 32 in the host, increasing likelihood of the presence of bacterial persisters post-treatment which may adapt to rifampin by inducing point mutations within the RRDR. "
